Dementia Action Week 2024: the future of Alzheimer’s diagnostics
As the debate over using tau levels to guide patient treatment persists, the landscape for Alzheimer’s diagnostics continues to move ahead.
Diagnostics
Drug delivery innovations push forth women’s health
Prothea debuts with $13m to develop cancer diagnostics and treatment
Q&A: BARDA wants to back tech that can combat multiple infections, says director
King Charles’ diagnosis raises awareness on prostate condition
Call for earlier diagnosis to improve Gaucher disease outcomes
UK seizes illegal medicines and devices worth over £84m in last 15 years
Novel CSF biomarkers signal new avenues for Parkinson’s therapeutics
